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Background/aim: Pulmonary embolism (PE) is a frequent health problem representing a diagnostic challenge with high mortality and
morbidity rates. The aim of this study was to investigate the value of end-tidal carbon dioxide (ETCO2) and alveolar dead space fraction
(ADSF) in the diagnosis of PE.
Materials and methods: ETCO2 levels of patients with suspected PE were measured with a noninvasive mainstream sensor. ADSF of
patients was calculated and PaCO2 levels were also obtained. ROC curve analysis was used to determine diagnostic values of ETCO2
and ADSF for PE.
Results: The study included 159 patients. The mean values for ETCO2 and ADSF were 16.27 (95% CI, 14.52–18.03) and 0.48 (95% CI,
0.43–0.539) in the PE group and 21.57 (95% CI, 20.52–22.639) and 0.35 (95% CI, 0.32–0.38) in the non-PE group. The area under the
curve (AUC) and the cut-off point for ETCO2 were found as 0.751 and ≤19, with 83.8% sensitivity and 61.5% specificity. AUC and cut-off
point for ADSF were found as 0.738 and >0.443, with 67.57% sensitivity and 73.77% specificity.
Conclusion: The diagnostic value of calculated ADSF and noninvasive bedside ETCO2 for PE was found to be low.
Key words: Pulmonary embolism, end-tidal carbon dioxide, alveolar dead space fraction, emergency department

1. Introduction
Pulmonary embolism (PE) is a frequently seen health
problem representing a diagnostic challenge with high
mortality and morbidity rates (1). Because of variations in
its symptoms and clinical findings, difficulties and delays
can be experienced in the diagnosis of PE. This is one of
the important reasons for higher mortality and morbidity.
In postmortem studies, higher rates of PE among all-cause
mortality demonstrate the seriousness of this condition
(2). Although mortality rates change, nearly 100,000
deaths are associated with PE in the United States every
year (3). Therefore, early diagnosis and treatment of PE
is life-saving (4). Since pulmonary angiography, which
is accepted as a gold standard, is an invasive, expensive,
and hardly applicable method, it has limited use in the
emergency department (ED). Due to difficulty in the
application of ventilation/perfusion (V/Q) scanning in
the ED, which yields results after a considerable time,
computed tomography (CT) angiography especially has
become an increasingly preferred imaging method in
* Correspondence: melihdr@gmail.com

84

the last decade (5–7). However, use of CT has certain
disadvantages, such as radiation exposure, use of contrast
agents, and logistic difficulties.
Monitorization of end-tidal carbon dioxide (ETCO2)
is a measurement method of carbon dioxide (CO2) in
exhaled air. This method was first used as a clinical
method in the 1970s by Smallhout and Kalenda (8).
Recently, utilization of the ETCO2 measurement method
in ED includes confirmation of endotracheal intubation,
monitorization of quality of cardiopulmonary resuscitation
and ventilation in unconscious patients, and evaluation
of pulmonary diseases (9–12). Alveolar CO2 exchange is
impaired in the area affected by vascular occlusion, which
induces PE, with a resultant increase in alveolar dead
space (13). Nunn described a method for the calculation
of the alveolar dead space, which is termed as alveolar
dead space fraction (ADSF) (14). Since the volume of the
previous alveolar dead space is not usually known, and
dead space may increase as a result of chronic bronchitis,
myocardial infarction, pulmonary hypertension, and
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shock, the accuracy of this method is not obvious. It has
been reported that ADSF can be used for the diagnosis of
PE (15–18).
The aim of the present study was to investigate the
accuracy of ETCO2, which can be measured by bedside
noninvasive mainstream capnometer, and ADSF in the
diagnosis of PE.
2. Materials and methods
2.1. Study design
The study was performed at the ED of a university hospital
with an annual census of 30,000 between 1 November
2010 and 31 October 2011. Approval was obtained by the
ethics committee (2010/37). Written consent of all patients
was also acquired.
2.2. Inclusion criteria
Adult patients who presented to the ED with nontraumatic
complaints suggesting PE were included in the study.
These complaints included shortness of breath, chest pain,
and unexplained syncope starting within the previous 48
h. Consent to participate was obtained.
2.3. Exclusion criteria
Pregnant women and patients with contrast allergy, renal
failure, or other alternative diagnoses (acute coronary
syndrome, chronic obstructive pulmonary disease,
pneumonia) or those lost to follow-up and individuals
who refused to participate were excluded from the study.
2.4. Outcome parameters
All patients were monitored and vital signs and clinical
data were recorded. Blood samples were drawn from
patients and sent to the central laboratory for the analysis
of D-dimer and arterial blood gas (ABG). D-Dimer was
analyzed using the macro-ELISA method (STA-LIATEST,
Asnières-sur-Seine, France) and a cut-off value of 0.5 µg/
mL, determined by the manufacturing firm, was used.
ABG analysis was performed using an ABL-700 radiometer
device. ETCO2 was measured noninvasively in all patients
with a mainstream sensor (TG-921T3 Nihon Kohden,
Tokyo, Japan). For each patient, ADSF was calculated
using the formula ADSF = (PaCO2 – PETCO2) / PaCO2.
The Wells scoring system was used to evaluate the
probability of clinical PE. The patients were divided
into 4 groups based on D-dimer test results for imaging
decisions:
1. High probability of clinical PE regardless of the
D-dimer test results (Wells score of >6).
2. D-Dimer-positive patients with a low (Wells score
<2) or moderate (Wells score 2–6) probability of PE.
3. D-Dimer-negative patients with a moderate
probability of PE (Wells score 2–6).
4. D-Dimer-negative patients with a low probability of
PE (Wells score <2).

In the patients of groups 1, 2 and 3, multislice thoracic
CT angiography (Toshiba Aqullion 64, Tokyo, Japan) was
performed. Group 4 did not undergo CT angiography, but
patients were reached by phone to enquire about sudden
death or development of PE.
Study subjects were assigned as either PE (study group)
or non-PE (control group) at the end of the follow-up
period. Demographic, clinical, and laboratory features of
the groups were compared. Diagnostic values of ETCO2
and ADSF were investigated for PE.
2.5. Statistical analysis
Statistical analysis was performed using MedCalc Statistical
Software 13.1.0 (MedCalc Software, Ostend, Belgium).
Normality of distribution of data was analyzed using
the one-sample Kolmogorov–Smirnov test. Quantitative
variables in demographic and clinical features were
expressed as percentages (%), and continuous variables
with mean and 95% confidence interval (CI). In the
comparison of variables in both groups, t-test and chisquare tests were used for independent samples. ROC
curves were drawn to analyze the diagnostic value of
ETCO2 and ADSF, and P < 0.05 was considered statistically
significant.
3. Results
A total of 189 patients were eligible for the study. Thirty
patients were excluded from the study and the analysis
was performed with 159 patients (Figure 1). Prevalence
of PE was 23.3% (37/159 patients). The study population
consisted of 85 (53.5%) female and 74 (46.5%) male
patients with a mean age of 58.68 years (95% CI: 56.25–
61.11). The most frequent complaints at presentation were
shortness of breath (n = 133; 83.6%) and palpitations (n
= 80; 50.3%). Fifty-five patients (34.6%) had pulmonary
malignancies. Six patients (16.2%) from the PE group (one
patient in the intensive care unit, five patients in wards)
and 9 patients (7.4%) from the non-PE group (one in the
intensive care unit, eight in wards) suffered in-hospital
mortality. Mean values of vital signs of the patients were
as follows: SBP, 135.55 mmHg (95% CI: 131.06–140.04);
DBP, 82.23 mmHg (95% CI: 79.15–85.30); pulse rate,
108.82 bpm (95% CI: 105.05–112.58); respiratory rate,
31.45/min (95% CI: 30.10–32.80). The demographic and
clinical features of the groups are presented in Table 1.
In patients with PE, mean ETCO2 was 16.27 mmHg
(95% CI: 14.52–18.03), while mean ADSF was found to be
0.48 (95% CI: 0.43–0.53). 0.53. The corresponding values
of the non-PE group for ETCO2 and ADSF were 21.57
mmHg (95% CI: 20.52–22.63) and 0.35 (95% CI: 0.32–
0.38), respectively. Higher D-dimer levels were identified
in patients with PE (Table 2).
ROC curves of ETCO2 and ADSF levels were drawn
for the diagnosis of PE. For ETCO2, the area under the
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Patients consulted the emergency service with
complaints suggesting pulmonary embolism (n = 189)
Excluded Patients (n = 30)
Renal failure (n = 4)
Pregnancy (n = 5)
Did not consent (n = 8)
STEMI (n = 1)
Sepsis (n = 1)
Anaphylaxis (n = 1)
Coronary failure (n = 3)
Entubated (n = 1)
Unstable (n = 2)
Lack of data (n = 3)
Computed tomography could
not be taken (n = 1)

Patients included
in the study
(n = 159)

High probability
! (n = 22)
!

PE (+): 10
PE (-): 12

Moderate
probability and Ddimer (+)
(n = 116)

Moderate
probability and D dimer (-)
(n = 9)

PE (+): 26
PE (-): 90
!

PE (+): 1
PE (-): 8
!

Low probability
and D- dimer (-)
(n = 12)

PE (+): 0
PE (-): 12
!

Figure 1. Selection of patients for the study group.
Table 1. Demographic and clinical features of the study groups.
PE (+)
Demographic features
Number of patients, n (%)
37 (23.3%)
Age, mean, years
62.08
Female sex, n (%)
21 (56.75%)
Exitus, n (%)
6 (16.21%)
Admission to hospital, n (%)
27 (75.00%)
Symptoms, n (%)
Dyspnea
30 (81.08%)
Palpitation
23 (62.16%)
Chest pain
19 (51.35%)
Loss of consciousness
17 (45.94%)
Syncope
4 (10.81%)
Hemoptysis
3 (8.10%)
Comorbidities, n (%)
Malignancy
11 (29.72%)
Previous deep vein thrombosis/PE
10 (27.02%)
Surgical intervention in the past month
14 (37.83%)
Probability of clinical PE (Wells scoring system), n (%)
High probability
10 (27.02%)
Moderate probability
25 67.56%)
Low probability
2 (5.40%)
Clinical features, n (%)
SBP, mmHg
134.38
DBP, mmHg
82.11
Pulse, /min
118.22
Respiratory rate, /min
32.24

PE (–)

P-value

122 (76.6%)
57.65
64 (52.46%)
9 (7.37%)
48 (39.66%)

0.128
0.786
0.117
<0.001
1.000

103 (84.42%)
57 (46.72%)
60 (49.18%)
37 (30.32%)
13 (10.65%)
13 (10.65%)

0.819
0.145
0.965
0.119
1.000
0.765

44 (36.06%)
14 (11.47%)
35 (28.68%)

0.608
0.040
0.394

12 (9.83%)
63 (51.63%)
47 (38.52%)

<0.001
1.000

135.90
82.26
105.97
31.21

0.778
0.967
0.006
0.526

PE: Pulmonary embolism; SBP: systolic blood pressure; DBP: diastolic blood pressure; CI: confidence interval.
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Table 2. D-Dimer, ETCO2, and ADSF values according to the study groups.
Variable

PE (+)

PE (–)

P-value

D-dimer, µg/mL

9.13 (6.63–13.63)

3.96 (2.98–4.94)

<0.001

ETCO2, mmHg

16.27 (14.52–18.03)

21.57 (20.52–22.63)

<0.001

ADSF

0.48 (0.43–0.53)

0.35 (0.32–0.38)

<0.001

PE: Pulmonary embolism; ETCO2: end-tidal carbon dioxide; ADSF: alveolar dead space fraction.

ROC curve (AUC) was found to be 0.751 (95% CI: 0.663–
0.838). The Youden index J value for ETCO2 of ≤19 (95%
CI: 12–19) was calculated as 0.45 (95% CI: 0.282–0.577).
For this value, sensitivity of 83.8% (95% CI: 68–93.8) and
specificity of 61.5% (95% CI: 52.2–70.1) were determined
(Figure 2). For ADSF, the AUC was found to be 0.738 (95%
CI: 0.651–0.824). The Youden index J value for >0.443
(95% CI: 0.288–0.480) was calculated as 0.413 (95% CI:
0.255–0.535). For this value, sensitivity and specificity
were found to be 67.57% (95% CI: 50.2–82) and 73.77%
(95% CI: 65–81.3), respectively (Figure 3). Diagnostic
performances of various cut-off values of ETCO2 and
ADSF are shown in Table 3.
4. Discussion
This study revealed low diagnostic values of ETCO2 as
measured by bedside noninvasive mainstream capnometer
and calculated ADSF for PE in ED patients with suspected
PE.

In similar studies, prevalence of PE was reported as
15%p40% (17–20). Prevalence of PE in this study was
similar to that of other studies.
Hemnes et al. reported that the mean ETCO2 values
they obtained using microstream capnograph were
comparable in patients with or without PE at 36.3 mmHg
and 35.5 mmHg, respectively (21). In cases with ETCO2
values of ≥36, sensitivity, specificity, and NPV values were
reported as 87.2%, 53%, and 96.6%, respectively. In our
study, the mean ETCO2 levels of patients with or without
PE differed. In addition, ETCO2 values were lower, and a
cut-off value of 19 mmHg was determined. We think that
this discrepancy arose from characteristics of the patient
population and measurement methods.
In studies that investigated the diagnostic value of
ADSF for PE, measurements were performed using
volumetric capnograph, sidestream, and mainstream
adaptors. In those studies, the cut-off value for ADSF
ranged between 0.15 and 0.40 with rates of sensitivity and

etCO2

adsf

100

100
Sensitivity : 83.8
Specificity: 61.5
Criterion: ≤19

80

60

Sensitivity

Sensitivity

80

40

Sensitivity: 67.6
Specificity : 73.8
Criterion : >0.443

60

40

20

20

0
0

20

40
60
100-Specificity

80

Figure 2. Sensitivity and specificity for ETCO2 of ≤19.

100

0

0

20

40
60
100-Specificity

80

100

Figure 3. Sensitivity and specificity for ADSF > 0.443.
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Table 3. Diagnostic values of various ETCO2 and ADSF values.
Criteria

Sensitivity

Specificity

PPV

NPV

+LR

–LR

ETCO2 ≤ 11

16.22

98.36

75

79.5

9.89

0.85

ETCO2 ≤ 19

83.78

61.48

39.7

92.6

2.17

0.26

ETCO2 ≤ 31

97.3

4.1

23.5

83.3

1.01

0.66

ADSF > 0.04

97.3

1.64

23.1

66.7

0.99

1.65

ADSF > 0.15

97.3

5.74

23.8

87.5

1.03

0.47

ADSF > 0.20

97.3

10.66

24.8

92.9

1.09

0.25

ADSF > 0.44

67.57

73.77

43.9

88.2

2.58

0.44

ADSF > 0.68

5.41

99.18

66.7

77.6

6.59

0.95

ETCO2: End-tidal carbon dioxide; ADSF: alveolar dead space fraction; PPV: positive predictive value; NPV: negative predictive value;
+LR: positive likelihood ratio; –LR: negative likelihood ratio.

specificity varying between 68.5% and 100% and between
20% and 81.5%, respectively. Sanchez et al. measured levels
of ETCO2 in 270 suspected PE patients using a CO2 flow
sensor mounted on a rubber mouthpiece resembling that of
a snorkel and reported rates of sensitivity and specificity for
ADSF of <0.15 as 68.5% and 81.5%, respectively (17). Kline
et al. reported rates of sensitivity and specificity for ADSF,
with 0.2 set as the cut-off, of 88.5% and 66% in 170 ICU
patients with suspected PE (19). Rodger et al. determined
an ADSF cut-off value of 0.15, which derived from ETCO2
measurements performed using a mainstream adaptor in
a volumetric capnograph. In that study, rates of sensitivity,
specificity, and negative predictive value of this cut-off
value were 92.6%, 29%, and 95.1%, respectively (22). Burki
et al. investigated the value of physiological dead space
in the diagnosis of PE and determined the ADSF cut-off
value as 0.40, with 100% sensitivity and 55% specificity
(23). Yoon et al. reported rates of sensitivity, specificity,
and false negativity when ETCO2 was measured with the
sidestream method. The calculated ADSF value was ≥0.2,
with 100%, 65%, and 0%, respectively (15). Verschuren et
al. expressed sensitivity and specificity of ETCO2 measured
by the sidestream method and calculated ADSF (<0.15)
as 96% and 26% for the exclusion of PE (24). Hogg et al.
determined 0.32 as the cut-off value of ADSF, calculated
with ETCO2 value and measured by mainstream method
with sensitivity and specificity rates of 95.3% and 20%,
respectively (16). In another multicenter study conducted
by Kline et al., sensitivity and specificity of the analysis
based only on ADSF were found to be 67.2% and 76.3%,
respectively (25).
The performance of capnography in PE diagnosis was
reported with a sensitivity of 0.8, specificity of 0.49, –LR
of 0.32, +LR of 2.4, and diagnostic odds ratio of 10.4. This
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suggested the potential use of ETCO2 in patients with
suspected PE who have low clinical probability with high
D-dimer levels (20).
In 49 (19.9%) of 246 patients who were examined in
the Department of Nuclear Medicine with suspected PE,
diagnosis of PE was confirmed, whereas in 34 (13.8%)
patients diagnosis could not be established. Rates of
sensitivity and specificity of the cut-off value of ADSF
(<0.15) for the exclusion of PE diagnosis were reported
as 79.5% and 70.3%, respectively (18). The study used
mainstream adaptors for the measurement of ETCO2 in the
first cohort of patients’ sidestream and in the last cohort.
Mean ADSF was found to be 0.27 and 0.11 in patients
with or without established diagnosis of PE, respectively.
However, in our study, mean ADSF values were calculated
as 0.48 and 0.35 in groups of patients with or without PE,
respectively.
Our calculated ADSF value is above the cut-off
value generally accepted in the literature. However, its
sensitivity and specificity are similar to those accepted in
the literature. Use of different measurement techniques
and diverse outcomes with the same technique have been
reported. We suggest that the most important factors
responsible for this difference are related to variability
in patient inclusion and measurement methods. In
many other studies, the sidestream technique has been
used more frequently for the measurement of ETCO2.
However, in our study, the measurements were performed
using the mainstream technique. In the sidestream
measurement technique, CO2 that accumulates in the air
sampling catheter may artificially increase the ETCO2
value measured by capnometer. In the mainstream
measurement technique, real-time measurements are
performed within the airway, which avoids the mixture
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of the air sample with other gases in the surrounding
atmosphere. However, mainstream measurement values
may be lower than sidestream measurement values (26).
The outcomes might be affected by the difference between
measurement techniques. Besides, as stated by Eriksson et
al., in the presence of underlying pulmonary disease, the
number of false results may increase (27).
Since this study was conducted at a single center,
the results are not generalizable. No power analysis
was performed before the initiation of the study for
the estimation of the sample size; thus, the study was
performed on eligible patients over a 1-year period. In
addition, a relatively higher number of patients with
malignancies among the study participants might affect the
outcomes. In this study, the cut-off value of D-dimer (0.5
ng/mL) recommended by the manufacturer was accepted

as a positive value so as to determine the patients who
would undergo CT. However, the mean D-dimer value of
patients without PE (3.96 ng/mL) was much higher than
the threshold value. Therefore, many patients might have
undergone unnecessary CT examinations. Moreover, since
baseline alveolar dead volume is not known, the presence
of other abnormalities, which increases alveolar dead
space, can lead to inappropriate interpretations.
This study yielded a low diagnostic value of calculated
ADSF and noninvasive bedside ETCO2 for PE in the ED.
This finding differs from the outcomes of several other
studies. We think that taking the method of measurement
into consideration and evaluating this measurement
together with pretest clinical probability will be more
useful. Further studies are needed on this subject.
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